Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial

作者：Jiajia Yuan, Jifang Gong, Zhi Peng, Tian Shu Liu, HJ Xu, Jianwei Yang, Jia Wei, Haiping Jiang, Yanhong Deng, Yusheng Wang, Changsong Qi, Cheng Lyu, Qiao Sun, Lei Mu, Lin Song, Xiaotian Zhang, Lin Shen · 发表于：British Journal of Cancer · 年份：2026 · DOI：10.1038/s41416-026-03511-0 · 研究领域：Fibroblast Growth Factor Research、Esophageal Cancer Research and Treatment、Gastrointestinal Tumor Research and Treatment